Piliscsaba, Hungary

György Dormán

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Magyar Tudományos Akadémia Természettudományi Kutatóközpont. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: György Dormán. Retrieved from https://idiyas.com/inventor/györgy-dormán-raejpsrs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: György Dormán: Innovator in Cancer Treatment

Introduction

György Dormán is a notable inventor based in Piliscsaba, Hungary. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.

Latest Patents

Dormán holds a patent for "MDR-reversing 8-hydroxy-quinoline derivatives." This invention relates to 8-hydroxy-quinoline derivatives that possess multidrug-resistance reversing activity. These compounds demonstrate improved selectivity and increased cytotoxicity towards multidrug-resistant cancer cells. The preparation and application of these derivatives are particularly relevant in the treatment of cancer, especially for multidrug-resistant variants.

Career Highlights

György Dormán is affiliated with the Hungarian Academy of Sciences, Natural Science Research Center. His work focuses on developing innovative solutions to combat cancer, showcasing his dedication to advancing medical science.

Collaborations

Dormán has collaborated with esteemed colleagues, including Gergely Szakács and Tibor Soós. Their joint efforts contribute to the ongoing research and development in the field of cancer treatment.

Conclusion

György Dormán's contributions to cancer research through his patented inventions highlight the importance of innovation in medical science. His work continues to pave the way for new treatments that address the challenges posed by multidrug-resistant cancer cells.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…